Navigation Links
Clinical Study Data Indicates that Celliant Reduces Pain
Date:6/25/2009

A just completed clinical study proves that revolutionary technical performance fiber actually reduces pain when worn in garments or slept on in bedding. Already proven to increase oxygen levels in the body, data from a new clinical study published in online journal BioMed Central (www.BioMedCentral.com) supports claims that Celliant reduces pain.

Santa Monica, CA (PRWEB) June 25, 2009 -- Already proven to increase oxygen levels in the body, data from a new clinical study published in online journal BioMedCentral.com supports claims that Celliant reduces pain.

Celliant is a specially formulated technical performance fiber designed to enhance oxygen levels in the body, aiding in comfort, healing, performance and overall wellness. Data analysis from a clinical study conducted by Robyn MB York and Ian L. Gordon, research scientists affiliated with Long Beach VA Healthcare System and UCI Medical Center, shows that the material also has potent pain relief capabilities. In a double blind study using measurement techniques successfully employed in FDA-supervised clinical trials of pain relief medications, the magnitude of pain relief reported by participants using products enhanced with Celliant was significantly greater than that reported by participants using placebo products. Hologenix, LLC, the company behind Celliant,
'/>"/>

Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved  

0

GOOD

Page: 1 2 3 4

Related medicine news :

1. Radiologists encouraged to look beyond cancer for clinically unseen diseases
2. Clinical depression linked to abnormal emotional brain circuits
3. Preclinical study suggests organ-transplant drug may aid in lupus fight
4. Provectus Pharmaceuticals, Inc. Begins Phase 2 Clinical Trial for Metastatic Melanoma
5. Good Clinical Practice Journal Awards: Winners Announced
6. Microsoft Helps Developers of Clinical User Interfaces Improve Efficiency, Patient Safety With Free Toolkit
7. Study Questions Dead-End Cancer Clinical Trials
8. Genomic Health Announces Multiple Studies on Oncotype DX(TM) Presented at 2007 American Society of Clinical Oncology (ASCO) Breast Cancer Symposium
9. Clinical trials present better alternatives for dialysis patients
10. Mirixa Debuts New Clinical Technology Solutions for Enhancing Patient Care
11. IMPACT initiative looks to improve patient participation in clinical trials

Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Clinical Study Data Indicates that Celliant Reduces Pain
Clinical Study Data Indicates that Celliant Reduces Pain
(Date:12/2/2009)... incidence of obesity could counter recent increas...ealthDay News) -- The overall health of the U.S. p..., largely because people have quit smoking in drov...n be wiped out if the rising obesity rates among A...trends in both smoking and obesity continue unchan...
(Date:12/2/2009)...prolongs life remains unclear, researchers say , ...ew research suggests that enzyme replacement thera...ple with Fabry disease, a rare illness that affect...ive disease, linked to the lack of an enzyme that ... be fatal because it boosts the risk for a stroke,...
(Date:12/2/2009)...NIA BEACH, Va., Dec. 2 By now, mos...eless cigarettes continue to grow in popularity. A...ble at the PremiumEcigarette - the new single piec... at the amazingly low price of $14.99. ,, "This...he e-cigarette at a very low price, before making ...
(Date:12/2/2009)... , New Directors Represent Diverse Healthcar...wire-USNewswire/ -- The membership of the National...ts Board of Directors and reappointed four current...wide range of healthcare stakeholders, including c... public and community healthcare. ,, The newly...
(Date:12/2/2009)...DELPHIA, Dec. 2 Independence Blue ...s contract with Lincoln Financial Group. IBC will ...proximately 10,000 Lincoln Financial Group employe...on. The Lincoln plan offerings will include the PP..., "I know I speak for all of us at Independence ...
Breaking Medicine News(10 mins):Health News:Health Gains From Lowered Smoking Rates in Jeopardy 2Health News:Health Gains From Lowered Smoking Rates in Jeopardy 3Health News:A Smokeless Holiday Season? Premium Electronic Cigarette Announces New Disposable Smokeless Cigarette Product 2Health News:National Quality Forum Members Elect Nine Directors to Board 2Health News:National Quality Forum Members Elect Nine Directors to Board 3Health News:Independence Blue Cross Secures All-Blue Contract with Lincoln Financial Group 2Health News:Independence Blue Cross Secures All-Blue Contract with Lincoln Financial Group 3
...chers at the University of Pennsylvania School of ...l cargo in nerve cells react differently when expo...ole in Alzheimers disease. , Dynein and kinesin ... to regulate protein traffic, the group found. But...
... Following is a,media statement attributable to B...ersey Hospital Association:, "NJHA applauds the s...ty Initiative report. This is a valuable document ...efforts. The confidential reporting and,collaborat...
...7 Immunosyn,Corporation (OTC Bulletin Board: IMYN... "Proof of Concept Trial" for the biopharmaceutica...e for treatment of Diabetic Ulcers., The Board of...and largest shareholder. Argyll Biotechnologies is...
...lished in the January 18 edition (Volume 28, Issue...ing action is the result of what is known as a non...uired for the development of the disease. A nonsen...work of protein fibers or filaments in the cell th...
...12 expected this spring, officials add , ,...ood and Drug Administration on Thursday issued a p...r cough and cold medicines should not be given to ... recent months, FDA officials said they were conce...
...ers a safe effective, and inexpensive alternative ...., BERKELEY SPRINGS, W.Va., Jan. 17 The US Food ...ugh and cold medicine is too risky,for babies and ...fe threatening side effects of cold and cough medi...
Other Medicine News:Health News:Alzheimer's molecule is a smart speed bump on the nerve-cell transport highway 2Health News:Immunosyn Announces the Successful Completion of First Phase 'Proof of Concept Trial' in Europe for Treatment of Diabetic Ulcers With Biopharmeceutical SF-1019 2Health News:Immunosyn Announces the Successful Completion of First Phase 'Proof of Concept Trial' in Europe for Treatment of Diabetic Ulcers With Biopharmeceutical SF-1019 3Health News:Scripps research scientists find new genetic mutation that halts the development of lupus 2Health News:Scripps research scientists find new genetic mutation that halts the development of lupus 3Health News:Cold Meds Not Safe for Kids Under 2, FDA Warns 2Health News:Cold Meds Not Safe for Kids Under 2, FDA Warns 3Health News:Cold Meds Not Safe for Kids Under 2, FDA Warns 4Health News:FDA to Declare Cold Medicines Too Risky, Homeopathy Offers a Safe Alternative 2
(Date:12/2/2009)..., , CENTENNIAL, Colo., Dec. 2 /PRNewswire/...ofit providers of skin, bone and soft tissue allog...,s largest processor of live cellular bone growth ...truly iconic symbol of hope as a float rider aboar...010 Tournament of Roses Parade®. Manuel Sala...
(Date:12/2/2009)..., , DUBLIN, Ohio, Dec. 2 /PRNewswire-FirstC...e Cox will serve on the company,s board of directo...ently served as executive vice president and presi...Corp. She completed her tenure with the company at..., Prior to her term at Schering-Plough, Cox ser...
(Date:12/2/2009)..., , ROCKVILLE, Md., Dec. 2 /PRNewswire-Fir...ported favorable initial results from the first st...ng the safety and immunogenicity of the company,s ...enza vaccine. Novavax is conducting this study in...to support registration of the vaccine in Mexico a...
Breaking Medicine Technology:AlloSource Sponsors Heroic Quadruple Amputee as Rider Aboard 2010 Donate Life Rose Parade Float 2AlloSource Sponsors Heroic Quadruple Amputee as Rider Aboard 2010 Donate Life Rose Parade Float 3Cardinal Health Names Carrie Cox to Board of Directors 2NOVAVAX Reports Positive Clinical Results from Pivotal Study of H1N1 Influenza Vaccine in Mexico 2NOVAVAX Reports Positive Clinical Results from Pivotal Study of H1N1 Influenza Vaccine in Mexico 3NOVAVAX Reports Positive Clinical Results from Pivotal Study of H1N1 Influenza Vaccine in Mexico 4Dendreon Announces Webcast Presentations at Upcoming Investor Conferences 14644 1Novavax Announces Poster Presentation at the 47th Annual Meeting of the IDSA 14642 1Novavax Announces Poster Presentation at the 47th Annual Meeting of the IDSA 14642 2Alexandria Real Estate Equities Inc Provides Update 14640 1Alexandria Real Estate Equities Inc Provides Update 14640 2Alexandria Real Estate Equities Inc Provides Update 14640 3Alexandria Real Estate Equities Inc Provides Update 14640 4
...ESS WIRE)--May 17, 2007 - Salix,Pharmaceuticals, L...18 investigator-initiated trials related to the Co...sease Week(R) 2007, which will be,held May 19-24, ...gest and most prestigious meeting in the world for...than 16,000 physicians,researchers and academics ...
...nted at Society for Investigative Dermatology, FRE...atics,recently announced new comparative clinical ...e ability to recognize, transport and,utilize L-er...,damage, and importantly, that (EGT) acts as a mor...e, scavenging reactive oxygen,species and reducing...
Other Medicine Technology:Salix Pharmaceuticals Previews Digestive Disease Week 2007 2Salix Pharmaceuticals Previews Digestive Disease Week 2007 3Salix Pharmaceuticals Previews Digestive Disease Week 2007 4Salix Pharmaceuticals Previews Digestive Disease Week 2007 5AGI Dermatics Presents Comparative Data That Indicates OCTN-1 Skin,Cells Have the Ability to Recognize, Transport and Utilize,L-ergothioneine (EGT) As A Protector Against Oxidative Damage 2
... DTX Series Multimode Detectors provide unmatched ... and automation needs. Capable of performing fluor...on the same instrument, the DTX Series can operate...amlessly with Beckman Coulters Biomek Laboratory A...
... DNA Expert: Detection of PCR, cDNA and Oligonucle...e reader for a variety applications that are quant... The instrument is suitable to handle assays in M... Cuvettes Independent whether you have to quanti...
...igned for High Throughput Screening (HTS), Analyst...aring all the detection modalities and assay perfo...rescence plarization, time-resolved fluorescence, ...integration into robotic environments, including t...
...igned exclusively for cell-based assays, the NOVOs...asurements in addition to the flexibility of an on...nts from plate to plate or from three reagent stat...he unit has two injectors that can accurately deli...
Medicine Products: